Rosetta Genomics Company Profile

05:13 EDT 21st March 2018 | BioPortfolio

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and state-of-the-art laboratory processes has led to the discovery of hundreds of biologically validated novel human microRNAs. Building on its strong patent position and proprietary platform technologies, Rosetta Genomics is working on the application of these technologies in the development of a full range of microRNA-based diagnostic tools. The company’s first three microRNA-based tests, miRview™ squamous, miRview™ mets and miRview™ meso, are commercially available through its Philadelphia-based CAP-accredited, CLIA-certified lab. Rosetta Genomics is the 2008 winner of the Wall Street Journal’s Technology Innovation Awards in the medical/biotech category. To learn more, please visit


10 Plaut St.,


Phone: +972 8 948 4755
Fax: +972 8 948 4766

News Articles [301 Associated News Articles listed on BioPortfolio]

Rosetta Genomics Ltd.: Genoptix Completes Acquisition of PersonalizeDx from Rosetta Genomics

-First step in the process of Genoptix acquiring all of Rosetta Genomics -Next step is the completion of a merger for $8 million in cash pursuant to which value to Rosetta Genomics' equity holders...

Rosetta Genomics Ltd.: Genoptix to Acquire Rosetta Genomics for $10 Million in Cash

The value to Rosetta Genomics' equity holders is preliminarily estimated to be $0.60 per ordinary share, after deductions for debt, warrant termination payments, fees, expenses and other items CAR...

Financial Contrast: Rosetta Genomics (ROSG) and Its Peers

Rosetta Genomics is one of 186 public companies in the "Biotechnology & Medical Research" industry, but how does it contrast to its peers? We will compare Rosetta Genomics to similar companies bas...

ValuEngine Upgrades Rosetta Genomics (ROSG) to Sell

Separately, Barrington Research cut Rosetta Genomics from an "outperform" rating to a "market perform" rating in a research report on Monday, December 18th. Rosetta Genomics traded down $0.06 during t...

Genoptix plans to acquire Rosetta Genomics for $10mm in cash; transaction later terminated

Oncology diagnostic lab Genoptix Inc. agreed to acquire all outstanding shares of Nasdaq-traded Israeli genomics company Rosetta Genomics Ltd. (cancer diagnostics).

Rosetta Genomics to be acquired by Genoptix in $10M deal

Rosetta Genomics will be acquired by hematology and solid tumor molecular profiling provider Genoptix under a $10 million all -More- 

Rosetta Genomics Ltd.: Genoptix Enters into Agreement to Market and Distribute Rosetta Genomics' Testing Services Worldwide

Genoptix Will Have Exclusive Distribution Rights in the U.S. and Non-exclusive Rights in Most Geographies Outside the U.S. CARLSBAD, CA, PHILADELPHIA, PA and REHOVOT, ISRAEL / ACCESSWIRE / March 13...

Rosetta Genomics Ltd.: Rosetta Genomics Announces Results from Extraordinary General Meeting of Shareholders to Vote on Proposed Merger with Genoptix

Although shares voted were more than 2-to-1 in favor of the merger, the proposal failed to secure a majority of shares outstanding Company considering alternative options with Genoptix LAKE FOREST...

Drugs and Medications [0 Results]


PubMed Articles [249 Associated PubMed Articles listed on BioPortfolio]

Protein structure prediction using Rosetta in CASP12.

We describe several notable aspects of our structure predictions using Rosetta in CASP12 in the free modeling (FM) and refinement (TR) categories. First, we had previously generated (and published) mo...

Genomics Education: Knowledge of Nurses Across the Profession and Integration Into Practice.

Since the completion of the Human Genome Project in 2003, the implications of genetics and genomics for health and illness have become clearer. All nurses, at all levels and across all specialties, mu...

Recent developments of software and database in microbial genomics and functional genomics.

Genetics and Genomics: An Oncology Nurse's Journey in Practice.

Cancer genetics and genomics are now an integral component of oncology care. Genetics and genomics guide recommendations not only for cancer prevention and early detection, but also for cancer treatme...

An Introduction to Integrative Genomics and Systems Medicine in Cancer.

In this Special Issue (SI), with a theme of "Integrative Genomics and Systems Medicine in Cancer", we have collected a total of 12 research and review articles from researchers in the field of genomic...

Clinical Trials [80 Associated Clinical Trials listed on BioPortfolio]

RandOmized Study Exploring the Combination of radioTherapy With Two Types of Acupuncture Treatment: The ROSETTA Trial

The ROSETTA-trial will evaluate the effect of acupuncture as a complementary treatment parallel to radiation therapy in oncological patients. The trial is designed as a two-armed trial. De...

Electronic Medical Records and Genomics (eMERGE) Phase III

The Electronic Medical Records and Genomics (eMERGE) Network is in its third phase and during this time is enrolling and sequencing 25,000 individuals on a custom sequencing panel of clini...

Genomics and Postoperative Atrial Fibrillation

This research study is done to find out if genetic make up of a person plays a role in complications and recovery after the Coronary Artery Bypass Graft (CABG) operation. As you may be aw...

Microfluidics and Transcriptomics in Post Solid Organ Transplant Patients

The field of genomics is an exciting new field being applied in medicine. Its use in treating some cancers, sepsis and burn patients has been very promising. As knowledge of genomics and a...

High Throughput Drug Sensitivity and Genomics Data in Developing Individualized Treatment in Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia

This pilot clinical trial studies whether using high throughput drug sensitivity and genomics data is feasible in developing individualized treatment in patients with multiple myeloma or p...

Companies [402 Associated Companies listed on BioPortfolio]

Rosetta Genomics

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics, Ltd.

Rosetta Genomics is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinformatics and sta...

Rosetta Genomics Ltd.

Rosetta Genomics (NASDAQ: ROSG) is a leading developer of microRNA-based molecular diagnostics. Founded in 2000, the company’s integrative research platform combining bioinfo...

Rosetta Genomics Ltd. and Biocept, Inc.

Rosetta develops and commercializes a full range of microRNA-based and other molecular diagnostics. Rosetta’s integrative research platform combining bioinformatics and state...

Rosetta Stone Inc.

Rosetta Stone Inc. is changing the way the world learns languages. Rosetta Stone provides interactive solutions that are acclaimed for the speed and power to unlock the natural la...

More Information about "Rosetta Genomics" on BioPortfolio

We have published hundreds of Rosetta Genomics news stories on BioPortfolio along with dozens of Rosetta Genomics Clinical Trials and PubMed Articles about Rosetta Genomics for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Rosetta Genomics Companies in our database. You can also find out about relevant Rosetta Genomics Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Prostate Cancer
Prostate cancer (cancer de prostata) Prostate cancer (cancer de prostata) is a form of cancer that develops in the prostate, a gland in the male reproductive system. Most prostate cancers are slow growing; however, there are cases of aggressive prostat...

Corporate Database Quicklinks

Searches Linking to this Company Record